The lack of natural immunity against HIV has been a major hindrance to the search for immune correlates of protection. Here, the authors propose a new approach for clinical trials of HIV vaccine efficacy that should help to increase our chances of identifying immune correlates of protection.
- Richard A. Koup
- Barney S. Graham
- Daniel C. Douek